📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Stereochemical inversion at a 1,4-cyclohexyl PROTAC linker fine-tunes conformation and binding affinity. (2024)

First Author: Pierri M

Attributed to: Development of LRRK2 PROTAC degraders as chemical probes and potential lead compounds for the treatment of Parkinson's disease funded by Horizon Europe Guarantee

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2024.129861

PubMed Identifier: 38942127

Publication URI: http://europepmc.org/abstract/MED/38942127

Type: Journal Article/Review

Volume: 110

Parent Publication: Bioorganic & medicinal chemistry letters

ISSN: 0960-894X